Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Weiden
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
American Journal of Psychiatry
Psychiatry
Mental Health
Related publications
Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial
MOJ Addiction Medicine & Therapy
Aripiprazol Versus Quetiapine in Treatment of Non-Affective Acute Psychosis: A Double-Blind, Randomized - Controlled Clinical Trial
American Journal of Psychiatry and Neuroscience
Effects of Olanzapine, Risperidone and Haloperidol on Prepulse Inhibition in Schizophrenia Patients: A Double-Blind, Randomized Controlled Trial
Schizophrenia Research
Psychiatry
Mental Health
Biological Psychiatry
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
American Journal of Psychiatry
Psychiatry
Mental Health
Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Comparison of the Effects of Sertindole and Olanzapine on Cognition (SEROLA): A Double-Blind Randomized 12-Week Study of Patients Diagnosed With Schizophrenia
Therapeutic Advances in Psychopharmacology
Comparison of Risperidone, Olanzapine and Quetiapine: Effects on Body Weight, Serum Blood Glucose and Prolactin
International Psychiatry
Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder
Therapeutics and Clinical Risk Management
Efficacy and Safety of Olanzapine for Treatment of Patients With Bipolar Depression: Chinese Subpopulation Analysis of a Double-Blind, Randomized, Placebo-Controlled Study
Neuropsychiatric Disease and Treatment
